The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
News|Articles|September 25, 2015
Ubl Named Next PhRMA President and CEO
Author(s)Pharmaceutical Technology Editors
Stephen J. Ubl to succeed John J. Castellani as the next president and chief executive officer of PhRMA.
Advertisement
The board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) on Sept. 25, 2015 named Stephen J. Ubl the next president and chief executive officer of the association. He succeeds John J. Castellani, who will be retiring at the end of the year.
Ubl joins PhRMA after more than 10 years as the president and CEO of the Advanced Medical Technology Association where he worked with patient advocacy organizations, providers, and public and private payers. He was a board member of the National Health Council.
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement